Welcome to the “Pharm So Hard Ambulatory Care Podcast,” part of the “Pharm So Hard Network.” This series is your go-to source for all things ambulatory care pharmacy. Join us as we explore medication therapy management, chronic disease management, innovative patient care models, and the latest in policy and practice updates. Featuring expert insights and real-world advice, our episodes are designed to empower pharmacy professionals to excel in outpatient care settings. Tune in to stay at the forefront of ambulatory care pharmacy practice and join a community of dedicated healthcare professionals committed to making a difference. Subscribe now and transform patient care with us.
All content for Pharm So Hard Ambulatory Care Podcast is the property of Micaela Hayes, PharmD & Morgan Grier, PharmD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the “Pharm So Hard Ambulatory Care Podcast,” part of the “Pharm So Hard Network.” This series is your go-to source for all things ambulatory care pharmacy. Join us as we explore medication therapy management, chronic disease management, innovative patient care models, and the latest in policy and practice updates. Featuring expert insights and real-world advice, our episodes are designed to empower pharmacy professionals to excel in outpatient care settings. Tune in to stay at the forefront of ambulatory care pharmacy practice and join a community of dedicated healthcare professionals committed to making a difference. Subscribe now and transform patient care with us.
Episode 5. Diving Deep: The Literature on GLP-1 Agonists
Pharm So Hard Ambulatory Care Podcast
31 minutes 59 seconds
1 year ago
Episode 5. Diving Deep: The Literature on GLP-1 Agonists
In this episode of the Pharm So Hard Ambulatory Care Podcast, the hosts discuss various studies and trials related to GLP-1 medications for weight management and cardiovascular outcomes. They provide updates on their personal lives and share their experiences with different vehicles, such as Jeeps and Broncos. The studies discussed include the Surmount 1 study, which showed significant weight loss in patients without diabetes; the Risk of Gastrointestinal Adverse Events Associated with GLP-1s study, which highlighted potential side effects of GLP-1 medications; the SELECT trial, which demonstrated the effectiveness of semaglutide in reducing cardiovascular events in patients with obesity and pre-existing cardiovascular disease; and a phase 2 trial of Retro-True Tide, a triple hormone receptor agonist that showed impressive weight loss results. The hosts also discuss the limitations and implications of these studies.
Takeaways
GLP-1 medications have shown significant weight loss in patients without diabetes.
GLP-1 medications may have gastrointestinal side effects, but the overall risk is small compared to the potential benefits.
Semaglutide has been shown to reduce cardiovascular events in patients with obesity and pre-existing cardiovascular disease.
Retro-True Tide, a triple hormone receptor agonist, has shown impressive weight loss results in a phase 2 trial.
It is important to consider the limitations and implications of these studies when evaluating the use of GLP-1 medications.
Pharm So Hard Ambulatory Care Podcast
Welcome to the “Pharm So Hard Ambulatory Care Podcast,” part of the “Pharm So Hard Network.” This series is your go-to source for all things ambulatory care pharmacy. Join us as we explore medication therapy management, chronic disease management, innovative patient care models, and the latest in policy and practice updates. Featuring expert insights and real-world advice, our episodes are designed to empower pharmacy professionals to excel in outpatient care settings. Tune in to stay at the forefront of ambulatory care pharmacy practice and join a community of dedicated healthcare professionals committed to making a difference. Subscribe now and transform patient care with us.
